Erythropoietic response after intravenous iron in patients with heart failure and reduced ejection fraction with and without background treatment with sodium-glucose cotransporter 2 inhibitors.
Autores da FMUP
Participantes de fora da FMUP
- Marques, P
- Matias, P
- Packer, M
- Vieira, JT
- Vasques Nóvoa, F
- Sharma, A
- Mavrakanas, TA
- Frioes, F
Unidades de investigação
Abstract
Filiações
Filiações não disponíveis
Proyectos asociados
Dapagliflozin, Spironolactone or Both for HFpEF (SOGALDI-PEF) - NCT05676684
Investigador Principal: João Pedro Melo Marques Pinho Ferreira
Ensaio Clínico Académico (SOGALDI-PEF) . AstraZeneca . 2022
Citar a publicação
Marques P,Matias P,Packer M,Vieira JT,Vasques F,Sharma A,Mavrakanas TA,Frioes F,Ferreira JP. Erythropoietic response after intravenous iron in patients with heart failure and reduced ejection fraction with and without background treatment with sodium-glucose cotransporter 2 inhibitors. Eur. J. Heart Fail. 2023. 25. (12):p. 2191-2198. IF:18,200. (1).